Daily Alpha · Reddit
· Midday Alpha · by Buzzberg Research
Reddit authors debated buying Nvidia after Huang's exit, while other threads covered Anthropic's IPO range, MSCI dropping Strategy and a one-month rotation from tech into healthcare.
Themes on this desk
Nvidia dip-buying
An r/stocks author says they are buying Nvidia this morning and an r/StockMarket author calls it a no-brainer buy at $150, while another r/stocks author expects a fall to around 130 before buying.
Highest engagement
by score · day changeHealthcare rose 11.4% and tech fell 11.2% in one month while the S&P 500 fell 2%
The author reports a one-month rotation out of tech into healthcare, with XLV up 11.4% and XLK down 11.2%, and asks readers whether they made the shift; no position is disclosed.
In one month, healthcare stocks rose 11% and tech fell 11%.
Sector leadership over the month has moved from tech to healthcare.
Watch Whether XLV keeps outperforming XLK.
Source →An r/energy author says freight has gone from 3-5% to 25-30% of delivered oil cost and pitches Heidmar
The author presents Heidmar as an asset-light way to benefit from structurally higher oil freight costs caused by reroutes and constrained vessel supply.
Freight has gone from 3-5% of delivered oil cost to 25-30%. The people collecting it aren’t the ship owners.
The author argues ship owners are not the ones collecting the higher freight.
Source →Anthropic set its IPO price range at $70-78 for 825 million shares
The author analyzes the IPO pricing, limited float and retail allocation, and questions whether the offering is worthwhile for small retail investors.
Anthropic set its initial public offering price range at $70-$78 for 825 million shares.
Limited float and retail allocation shape access to the listing.
Watch Final pricing against the $70-78 range.
Source →MSCI is dropping Strategy from its indexes under a non-operating company rule
The post notes Strategy had $125 million of revenue and $19.5 billion of net income last quarter and asks whether it is a software company or a bitcoin fund; no position is disclosed.
MSCI is dropping Strategy from its indexes.
MSCI's rule treats Strategy as a non-operating company.
Source →In a thread on Infineon's record quarter and FY2027 outlook, a commenter says to anchor on free cash flow
A commenter argues Infineon's recurring M&A spending is part of its growth model, so investors should anchor on reported free cash flow and size positions to survive 50-70% chip-cycle drawdowns.
I'd run the same test on the M&A line.
The commenter treats recurring M&A as part of Infineon's growth model rather than a one-off.
Source →Most argued
by comments per upvoteNebius falls 10% as company expects increased 2026 capex spend, issues weak outlook
News recap of Nebius's Q3 results and higher 2026/2027 capex guidance with weak outlook, without the author's own investment view.
Nebius falls 10% as company expects increased 2026 capex spend, issues weak outlook Nebius shares sank 10% on Thursday asSource →
Each SPY rebound since October 6 has topped out lower than the one before
The author argues SPY's series of lower rebound highs since its October 6 close of 779.09 signals a continuing pullback rather than a recovery.
Each rebound since Oct 6 has topped out loser than the one before it SPY closed at 779.09 on Oct
The pattern argues against calling a bottom yet.
Watch A rebound that clears the previous rebound high.
Source →An r/pennystocks author is long Quantum Helium, citing proven helium and a stimulation program underway
The author cites the Sagebrush-1 stimulation program, existing oil revenue and a large Colorado acreage position, while flagging unproven commercial flow rates and funding risk.
QHELF (OTC) : Helium proven, stimulation underway, oil revenues growing, and a large Colorado acreage position **Disclosure:** Long QHELF.
Commercial flow rates are the unproven part of the thesis.
Watch Results of the Sagebrush-1 stimulation program.
Source →